Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease in Europe
TOKYO, Jan 11, 2023 – (J […]
Toyota City, Japan, Jan 10, 20 […]
SUNNYVALE, CA and TOKYO, Jan 1 […]
TOKYO and CAMBRIDGE, Mass., Ja […]
TOKYO, Jan 6, 2023 – (JC […]
SAN JOSE, CA, Jan 6, 2023 R […]
HIROSHIMA, Japan, Dec 26, 2022 […]
Toyota City, Japan, Dec 26, 20 […]
TOKYO, Dec 26, 2022 – (J […]
TOKYO, Dec 22, 2022 – (J […]
TOKYO and BANGKOK, Dec 22, 202 […]